Browsing: Exit

The chief financial officers are leaving the payments players as the companies grapple with separate challenges.

Another massive deal in the cyber sector: Cybersecurity company Proofpoint, owned by private equity firm Thoma Bravo, will acquire Israeli information security firm Varonis Systems in a cash deal valued at approximately $6.3 billion.

Two startup electricity retailers in Germany have announced they will stop operating as sharply higher wholesale prices tied to the gas price surge pressure the sector once more, with the strain this time compounded by planned changes to renewable energy policy, according to Oilprice.com. Gruuun, a renewable electricity provider within Munch Energie Group, said earlier…

Add preferred source Shopify’s 2026 decision to abandon React Native for Swift and Kotlin sent a chill through the mobile development world, but the framework’s most vocal defender says the move has less to do with React Native’s technical merits than with a fundamental shift in who writes code now. Theo Browne, host of the…

CPI Card Group Inc. (PMTS) is registering a resale of 2,337,323 shares of common stock being sold by existing stockholders, primarily Tricor Pacific Capital Partners (Fund IV) entities.

Sun Communities showcases a delevered, pure-play MH and RV platform with higher 2026 Core FFO guidance and an expected $1.03 billion all-cash UK asset sale.

Nissha Co. Ltd. plans to fully divest its controlling stake in Vietnamese medical device maker USM Healthcare Medical Devices Factory JSC, less than four months after acquiring the company, following the discovery of accounting irregularities related to circular transactions before the acquisition.

We’ve uncovered the 11 dividend fortresses yielding 5%+ that don’t just survive market storms, but thrive in them.

AI is about to change healthcare. These 37 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10b in market cap – there’s still time to get in early.

ANAVEX LIFE SCIENCES CORP. (AVXL) reported a sharp improvement in results for the quarter ended June 30, 2026, driven by large reversals of share-based compensation after the former CEO’s termination. Operating expenses turned into a $6.7 million recovery versus $14.5 million of expenses a year earlier, and net income was $7.8 million (basic and diluted $0.08 per share)…